- Home
- ISPC vs TCRT Comparison
ISPC vs TCRT Comparison
Compare ISPC & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPC
- TCRT
- Stock Information
- Founded
- ISPC 2009
- TCRT 1998
- Country
- ISPC United States
- TCRT United States
- Employees
- ISPC N/A
- TCRT N/A
- Industry
- ISPC Precision Instruments
- TCRT Biotechnology: Pharmaceutical Preparations
- Sector
- ISPC Health Care
- TCRT Health Care
- Exchange
- ISPC Nasdaq
- TCRT Nasdaq
- Market Cap
- ISPC 6.9M
- TCRT 7.0M
- IPO Year
- ISPC 2021
- TCRT N/A
- Fundamental
- Price
- ISPC $0.86
- TCRT $2.69
- Analyst Decision
- ISPC
- TCRT
- Analyst Count
- ISPC 0
- TCRT 0
- Target Price
- ISPC N/A
- TCRT N/A
- AVG Volume (30 Days)
- ISPC 594.2K
- TCRT 1.3M
- Earning Date
- ISPC 11-14-2025
- TCRT 11-13-2025
- Dividend Yield
- ISPC N/A
- TCRT N/A
- EPS Growth
- ISPC N/A
- TCRT N/A
- EPS
- ISPC N/A
- TCRT N/A
- Revenue
- ISPC $5,908,088.00
- TCRT $6,000.00
- Revenue This Year
- ISPC $35.93
- TCRT $5,680,500.00
- Revenue Next Year
- ISPC N/A
- TCRT N/A
- P/E Ratio
- ISPC N/A
- TCRT N/A
- Revenue Growth
- ISPC N/A
- TCRT N/A
- 52 Week Low
- ISPC $0.64
- TCRT $1.31
- 52 Week High
- ISPC $5.48
- TCRT $6.20
- Technical
- Relative Strength Index (RSI)
- ISPC 44.70
- TCRT 46.26
- Support Level
- ISPC $0.72
- TCRT $2.51
- Resistance Level
- ISPC $0.91
- TCRT $2.90
- Average True Range (ATR)
- ISPC 0.08
- TCRT 0.30
- MACD
- ISPC 0.00
- TCRT -0.07
- Stochastic Oscillator
- ISPC 49.46
- TCRT 8.74
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.